Neil Singla

About Neil Singla

Dr. Neil Singla is a nationally recognized key opinion leader in analgesic protocol design and implementation. He has published extensively and is a frequent lecturer for physicians, pharmaceutical companies and medical research institutes throughout the country. For the past several years, the main focus of Dr. Singla\'s academic endeavors has been to analyze and understand how the inherent variability in subjective endpoint clinical trials can be minimized. He has developed novel techniques for patient education designed to minimize variability, reduce placebo response and increase effect size.Dr. Singla chairs the Clinical Trials Special Interest Group for the International Association for the Study of Pain and organized/ chaired the Conference on Analgesic Trials scientific symposium for both the IASP and the American Pain Society. Dr. Singla pioneered and developed the use of abdominoplasty as an acute postoperative pain clinical trial model; abdominoplasty is now a common pivotal soft tissue model and has played a key role in multiple new drug approvals.

Experience

1. Chief Medical Officer

   Latigo Biotherapeutics, Inc.

   Apr 2024 — Present

Education

• Northeast Ohio Medical University (NEOMED)

  Doctor of Medicine (MD)

  1992 — 1996

• The University of Akron

  Bachelor of Science (BS)

  1988 — 1992

Skills

• Drug Discovery
• Clinical Trials
• CRO
• Drug Development
• Gcp
• Hospitals
• Anesthesiology
• Medicine
• Pain
• Translational Medicine
• Protocol
• Medical Affairs
• Clinical Development
• Neuroscience
• Lifesciences
• Pain Management
• Drug Delivery
• Neurology
• Biotechnology
• Pharmaceutical Industry
• Fda
• Therapeutic Areas
• Clinical Research
• Clinical Pharmacology